163 related articles for article (PubMed ID: 8557223)
1. Risk of breast cancer in a cohort of infertile women.
Rossing MA; Daling JR; Weiss NS; Moore DE; Self SG
Gynecol Oncol; 1996 Jan; 60(1):3-7. PubMed ID: 8557223
[TBL] [Abstract][Full Text] [Related]
2. Risk of cutaneous melanoma in a cohort of infertile women.
Rossing MA; Daling JR; Weiss NS; Moore DE; Self SG
Melanoma Res; 1995 Apr; 5(2):123-7. PubMed ID: 7620340
[TBL] [Abstract][Full Text] [Related]
3. In situ and invasive cervical carcinoma in a cohort of infertile women.
Rossing MA; Daling JR; Weiss NS; Moore DE; Self SG
Fertil Steril; 1996 Jan; 65(1):19-22. PubMed ID: 8557140
[TBL] [Abstract][Full Text] [Related]
4. Infertility, ovulation induction treatments and the incidence of breast cancer--a historical prospective cohort of Israeli women.
Lerner-Geva L; Keinan-Boker L; Blumstein T; Boyko V; Olmar L; Mashiach S; Rabinovici J; Potashnik G; Lunenfeld E; Schenker JG; Shushan A; Fishman A; Cohen I; Vagman I; Lunenfeld B
Breast Cancer Res Treat; 2006 Nov; 100(2):201-12. PubMed ID: 16685587
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer incidence after hormonal infertility treatment in Sweden: a cohort study.
Orgéas CC; Sanner K; Hall P; Conner P; Holte J; Nilsson SJ; Sundfeldt K; Persson I; Chia KS; Wedren S; Dickman PW; Czene K
Am J Obstet Gynecol; 2009 Jan; 200(1):72.e1-7. PubMed ID: 19121659
[TBL] [Abstract][Full Text] [Related]
6. Ovarian tumors in a cohort of infertile women.
Rossing MA; Daling JR; Weiss NS; Moore DE; Self SG
N Engl J Med; 1994 Sep; 331(12):771-6. PubMed ID: 8065405
[TBL] [Abstract][Full Text] [Related]
7. Ovarian cancer risk after the use of ovulation-stimulating drugs.
Brinton LA; Lamb EJ; Moghissi KS; Scoccia B; Althuis MD; Mabie JE; Westhoff CL
Obstet Gynecol; 2004 Jun; 103(6):1194-203. PubMed ID: 15172852
[TBL] [Abstract][Full Text] [Related]
8. Risk of breast cancer in women treated with ovarian stimulation drugs for infertility: a systematic review and meta-analysis.
Beebeejaun Y; Athithan A; Copeland TP; Kamath MS; Sarris I; Sunkara SK
Fertil Steril; 2021 Jul; 116(1):198-207. PubMed ID: 34148584
[TBL] [Abstract][Full Text] [Related]
9. Thyroid cancer risk in women with infertility and association with fertility medications in Taiwan.
Ding DC; Chen W; Wang JH; Lin SZ; Sung FC
Cancer; 2019 May; 125(10):1701-1708. PubMed ID: 30645760
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the effects of letrozole and clomiphene citrate for ovulation induction in infertile women with polycystic ovary syndrome.
Nahid L; Sirous K
Minerva Ginecol; 2012 Jun; 64(3):253-8. PubMed ID: 22635021
[TBL] [Abstract][Full Text] [Related]
11. Infertility treatment and the risk of cancer.
Storeng R; Vangen S; Omland AK; Oldereid NB
Tidsskr Nor Laegeforen; 2012 Nov; 132(22):2494-9. PubMed ID: 23338030
[TBL] [Abstract][Full Text] [Related]
12. Cancer incidence in a cohort of infertile women.
Modan B; Ron E; Lerner-Geva L; Blumstein T; Menczer J; Rabinovici J; Oelsner G; Freedman L; Mashiach S; Lunenfeld B
Am J Epidemiol; 1998 Jun; 147(11):1038-42. PubMed ID: 9620047
[TBL] [Abstract][Full Text] [Related]
13. Anastrozole vs. clomiphene citrate in infertile women with ovulatory dysfunction: a phase II, randomized, dose-finding study.
Tredway D; Schertz JC; Bock D; Hemsey G; Diamond MP
Fertil Steril; 2011 Apr; 95(5):1720-4.e1-8. PubMed ID: 21300344
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer risk associated with ovulation-stimulating drugs.
Brinton LA; Scoccia B; Moghissi KS; Westhoff CL; Althuis MD; Mabie JE; Lamb EJ
Hum Reprod; 2004 Sep; 19(9):2005-13. PubMed ID: 15217997
[TBL] [Abstract][Full Text] [Related]
15. Uterine cancer after use of clomiphene citrate to induce ovulation.
Althuis MD; Moghissi KS; Westhoff CL; Scoccia B; Lamb EJ; Lubin JH; Brinton LA
Am J Epidemiol; 2005 Apr; 161(7):607-15. PubMed ID: 15781949
[TBL] [Abstract][Full Text] [Related]
16. Predictors of chances to conceive in ovulatory patients during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility.
Imani B; Eijkemans MJ; te Velde ER; Habbema JD; Fauser BC
J Clin Endocrinol Metab; 1999 May; 84(5):1617-22. PubMed ID: 10323389
[TBL] [Abstract][Full Text] [Related]
17. A case-control study of ovarian cancer in relation to infertility and the use of ovulation-inducing drugs.
Rossing MA; Tang MT; Flagg EW; Weiss LK; Wicklund KG
Am J Epidemiol; 2004 Dec; 160(11):1070-8. PubMed ID: 15561986
[TBL] [Abstract][Full Text] [Related]
18. A randomized controlled trial of combination letrozole and clomiphene citrate or letrozole alone for ovulation induction in women with polycystic ovary syndrome.
Mejia RB; Summers KM; Kresowik JD; Van Voorhis BJ
Fertil Steril; 2019 Mar; 111(3):571-578.e1. PubMed ID: 30683591
[TBL] [Abstract][Full Text] [Related]
19. Clomiphene citrate for ovulation induction in women with oligo-amenorrhoea.
Hughes E; Collins J; Vandekerckhove P
Cochrane Database Syst Rev; 2000; (2):CD000056. PubMed ID: 10796477
[TBL] [Abstract][Full Text] [Related]
20. Long-term relationship of ovulation-stimulating drugs to breast cancer risk.
Brinton LA; Scoccia B; Moghissi KS; Westhoff CL; Niwa S; Ruggieri D; Trabert B; Lamb EJ
Cancer Epidemiol Biomarkers Prev; 2014 Apr; 23(4):584-93. PubMed ID: 24700523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
